Marker Therapeutics, Inc. (MRKR)

1.44 +0.07 (+5.11%) USD  |  NASDAQ  |  Mar 04, 16:00
1.45 +0.01 (+0.69%) After-Hours: 20:00
More

Marker Therapeutics Interest Paid Supplemental Data (TTM)

Interest Paid Supplemental Data (TTM) Chart

View Interest Paid Supplemental Data (TTM) for MRKR.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Interest Paid Supplemental Data (TTM) Chart
Start Trial

Historical Data

View Historical Data
Start Trial

Interest Paid Supplemental Data (TTM) Range, Past 5 Years

View Interest Paid Supplemental Data (TTM) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Interest Paid Supplemental Data (TTM) Benchmarks

View Interest Paid Supplemental Data (TTM) Benchmarks
Start Trial
ADMA Biologics, Inc. Upgrade
Viridian Therapeutics, Inc. Upgrade
ACADIA Pharmaceuticals, Inc. Upgrade
Kiniksa Pharmaceuticals International Plc Upgrade
Neurocrine Biosciences, Inc. Upgrade